Veronica Crespi
Varese, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.
Journal: Prostate cancer and prostatic diseases
Published: January 03, 2026
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC.
Journal: Future oncology (London, England)
Published: April 28, 2025
Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 11, 2025
The evolving landscape of stage III unresectable non-small cell lung cancer "between lights and shadows".
Journal: Cancer treatment reviews
Published: January 17, 2025
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide.
Journal: Clinical genitourinary cancer
Published: June 25, 2024
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives.
Journal: Clinical genitourinary cancer
Published: April 25, 2024
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 15, 2023
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
Journal: Research and reports in urology
Published: September 04, 2022
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
Journal: Cells
Published: April 29, 2022
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience.
Journal: ESMO open
Published: February 13, 2022
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature.
Journal: Cancer treatment reviews
Published: November 16, 2021
Last Updated: 09/26/2026